A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors.

Montefiore Medical Center, The Bronx

Sinai Hospital of Baltimore- Alvin and Lois Lapidus Cancer Institute, Baltimore

James Graham Brown Cancer Center, Louisville

Indiana University Cancer Pavilion, Indianapolis

UT Health Science Center at San Antonio- Cancer Therapy and Research Center, San Antonio

Hunstman Cancer Institute, Salt Lake City

Sarcoma Oncology Center, Santa Monica

University of California San Diego, La Jolla